Article
The A391E mutation enhances FGFR3 activation in the absence of ligand.
Biochimica et biophysica acta - 1 Aug 2011
Chen Fenghao, Degnin Catherine, Laederich Melanie, Horton William A, Hristova Kalina
Abstract excerpt
The A391E mutation in the transmembrane domain of fibroblast growth factor receptor 3 leads to aberrant development of the cranium. It has been hypothesized that the mutant glutamic acid stabilizes the dimeric receptor due to hydrogen bonding and enhances its ligand-independent activation. We previously tested this hypothesis in lipid bilayers and showed that the mutation stabilizes the isolated transmembrane...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
